The 340B drug discount program: Hospitals generate profits by expanding to reach more affluent communities

Health Affairs

Volumn 33, Issue 10, 2014, Pages 1786-1792

  Conti, Rena M ^a   Bach, Peter B ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACT; ARTICLE; DRUG COST; HEALTH INSURANCE; HOSPITAL FINANCE; HUMAN; LOWEST INCOME GROUP; MEDICALLY UNINSURED; OUTPATIENT DEPARTMENT; PROFIT; UNITED STATES; VETERANS HEALTH CARE ACT; DEMOGRAPHY; ECONOMICS; LEGISLATION AND JURISPRUDENCE; MEDICARE; SAFETY NET HOSPITAL; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

PRESCRIPTION DRUG;

DRUG COSTS; HUMANS; MEDICALLY UNINSURED; MEDICARE; PRESCRIPTION DRUGS; RESIDENCE CHARACTERISTICS; SAFETY-NET PROVIDERS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84907829457     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2014.0540     Document Type: Article

References (23)

1. Government Accountability Office. Drug pricing: manufacturer discounts in the 340B program offer benefits, but federal oversight needs improvement [Internet]. Washington (DC): GAO; 2011 Sep [cited 2014 Aug 28]. Available from: http:// gao.gov/assets/330/323702.pdf
2. Conti RM, Bach PB. Cost consequences of the 340B drug discount program. JAMA. 2013; 309(19):1995-6.
3. Grassley CE. Letter to Mary K. Wakefield [Internet]. Washington (DC): Senate Committee on the Judiciary; 2013 Mar 27 [cited 2014 Aug 28]. Available from: http:// www.grassley.senate.gov/sites/ default/files/about/upload/2013-03-27-CEG-to-HRSA-340B-Oversight-3.pdf
4. Alexander A, Garloch K, Neff J. Nonprofit hospitals thrive on profits. Charlotte Observer. 2012 Apr 21.
5. Pollack A. Dispute develops over discount drug program. New York Times. 2013 Feb 12.
6. Census Bureau. American Fact-Finder: community facts [Internet]. Washington (DC): Census Bureau; [cited 2014 Aug 28]. Available from: http://factfinder2.census.gov/faces/ nav/jsf/pages/index.xhtml
7. To access the Appendix, click on the Appendix link in the box to the right of the article online
8. Garloch K, Alexander A. Oncologists struggle to stay independent. Charlotte Observer. 2012 Sep 22.
9. Fitch K, Pyenson B. Site of service cost differences for Medicare patients receiving chemotherapy [Internet]. Seattle (WA): Milliman; 2011 Oct 19 [cited 2014 Aug 28]. Available from: http://publications.milliman.com/publications/health-published/ pdfs/site-of-service-costdifferences. pdf
10. Moran Company. Results of analyses for chemotherapy administration utilization and chemotherapy drug utilization, 2005-2011 for Medicare fee-for-service beneficiaries [Internet]. Arlington (VA): Moran Company; 2013 May 29 [cited 2014 Aug 28]. Available from: http:// glacialblog.com/userfiles/76/ Moran_Site_Shift_Study_P1.pdf
11. Carrier ER, Dowling M, Berenson RA. Hospitals' geographic expansion in quest of well-insured patients: will the outcome be better care, more cost, or both? Health Aff (Millwood). 2012;31(4):827.
12. Baker LC, Bundorf MK, Kessler DP. Vertical integration: hospital ownership of physician practices is associated with higher prices and spending. Health Aff (Millwood). 2014;33(5):756-63.
13. Cutler DM, Scott Morton F. Hospitals, market share, and consolidation. JAMA. 2013;310(18):1964-70.
14. Welch WP, Cuellar AE, Stearns SC, Bindman AB. Proportion of physicians in large group practices continued to grow in 2009-11. Health Aff (Millwood). 2013;32(9): 1659-66.
15. Casalino LP, November EA, Berenson RA, Pham HH. Hospitalphysician relations: two tracks and the decline of the voluntary medical staff model. Health Aff (Millwood). 2008;27(5):1305-14.
16. Kocher R, Sahni NR. Hospitals' race to employ physicians-the logic behind a money-losing proposition. N Engl J Med. 2011;364(19):1790-3.
17. Berenson RA, Ginsburg PB, May JH. Hospital-physicians relations: cooperation, competition, or separation? Health Affairs (Millwood). 2007; 26(1):w31-43. DOI: 10.1377/hlthaff.26.1.w31.
18. Cuellar AE, Gertler PJ. Strategic integration of hospitals and physicians. J Health Econ. 2006;25(1): 1-28.
19. Levinson DR. Review of selected physician practices' procedures for tracking drug administration costs and ability to purchase cancer drugs at or below Medicare reimbursement rates [Internet]. Washington (DC): Department of Health and Human Services, Office of Inspector General; 2007 Jul [cited 2014 Aug 28]. (Report No. A-09-05-00066). Available from: https://oig.hhs.gov/oas/ reports/region9/90500066.pdf
20. Barr TR, Towle EL. Oncology practice trends from the National Practice Benchmark, 2005 through 2010. J Oncol Pract. 2011;7(5):286-90.
21. Barr TR, Towle EL. Oncology practice trends from the National Practice Benchmark. J Oncol Pract. 2012;8(5):292-7.
22. Towle EL, Barr TR, Senese JL. National Oncology Practice Benchmark, 2012 report on 2011 data. J Oncol Pract. 2012;8(6):51s-70s.
23. Castellon YM, Bazargan-Hejazi S, Masatsugu M, Contreras R. The impact of patient assistance programs and the 340B Drug Pricing Program on medication cost. Am J Manag Care. 2014;20(2):146-50.